ROMA (Risk of Ovarian Malignancy Algorithm)

ورودی‌های بالینی بیمار

حداقل ۱ — حداکثر ۱۰۰۰۰ • واحد: pmol/L

حداقل ۱ — حداکثر ۱۰۰۰۰۰ • واحد: U/mL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
roma
—%
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low risk (pre)0–11.4
  • High risk11.4–100
Direct Clinical Answer

The ROMA (Risk of Ovarian Malignancy Algorithm) calculates calculating gestational age, evaluating maternal-fetal wellbeing, and assessing perinatal complications. Key inputs include menopausal. Scores guide determining delivery timing, administering antenatal corticosteroids or tocolytics, and obstetric monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Combines HE4, CA125 and menopausal status into a malignancy risk percentage for adnexal masses.

Clinical Indication

The ROMA (Risk of Ovarian Malignancy Algorithm) is indicated for bedside clinical practice to support Combines HE4, CA125 and menopausal status into a malignancy risk percentage for adnexal masses.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Pregnant individuals across antepartum, intrapartum, and postpartum stages, or patients with acute gynecologic conditions. Clinical application is indicated across Labor and delivery suites, obstetric triage, antenatal clinics, and gynecologic surgical units.

Limitations & Contraindications

Normal gestational physiological adaptations alter baseline plasma volume, serum creatinine, and resting heart rate.

Clinical Pearls & Action Plan

Simultaneous surveillance of maternal hemodynamic stability and continuous electronic fetal heart rate monitoring is paramount.

Formula & Variables:

PI pre: -12.0+2.38 ln(HE4)+0.0626 ln(CA125); PI post: -8.09+1.04 ln(HE4)+0.732 ln(CA125); ROMA = e^PI/(1+e^PI) x 100

Input Parameters

NameTypeRequiredDescription
menopausalstringYesMenopausal status
he4floatYesHE4(pmol/L)
ca125floatYesCA125(U/mL)

Score Interpretation & Guidance

RangeStageDescription
0–11.4Low risk (pre)Below high-risk cutoff
11.4–100High riskAt/above high-risk cutoff

Evidence-Based References (EBM)

  • Moore RG, McMeekin DS, Brown AK, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol. 2009;112(1):40-46.

Related calculators